Cargando…

A four-step process for building sustainable access to diagnosis and treatment of Chagas disease

The vast majority of people with Chagas disease (CD) are undiagnosed and untreated. Improving access to diagnosis and treatment for CD involves confronting a wide range of barriers. This report discusses a collaborative approach to eliminate barriers and increase the availability of CD testing and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batista, Carolina, Forsyth, Colin J, Herazo, Rafael, Certo, Marina Pereira, Marchiol, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Organización Panamericana de la Salud 2019
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758842/ https://www.ncbi.nlm.nih.gov/pubmed/31582959 http://dx.doi.org/10.26633/RPSP.2019.74

Ejemplares similares

Increasing access to comprehensive care for Chagas disease: development of a patient-centered model in Colombia
por: Marchiol, Andrea, et al.
Publicado: (2017)

Laboratory evaluation of eleven rapid diagnostic tests for serological diagnosis of Chagas disease in Colombia
por: Marchiol, Andrea, et al.
Publicado: (2023)

Mandatory Notification of Chronic Chagas Disease: Confronting the Epidemiological Silence in the State of Goiás, Brazil
por: da Rocha Siriano, Liliane, et al.
Publicado: (2020)

Evaluación del cambio del algoritmo de diagnóstico serológico para la enfermedad de Chagas en Colombia
por: Marchiol, Andrea Rosana, et al.
Publicado: (2023)

Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States
por: Forsyth, Colin, et al.
Publicado: (2019)

Barriers to Diagnosis Access for Chagas Disease in Colombia
por: Olivera, Mario Javier, et al.
Publicado: (2018)

"I Cannot Be Worried": Living with Chagas Disease in Tropical Bolivia
por: Forsyth, Colin J.
Publicado: (2017)

Treatment of Chagas Disease in the United States
por: Meymandi, Sheba, et al.
Publicado: (2018)

Building a Sustainable Comprehensive Multiple Myeloma Program in Western Kenya
por: Oduor, Mercy A., et al.
Publicado: (2021)

Recommendations for Screening and Diagnosis of Chagas Disease in the United States
por: Forsyth, Colin J, et al.
Publicado: (2021)

Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease
por: Olivera, Mario J., et al.
Publicado: (2017)

“It’s Like a Phantom Disease”: Patient Perspectives on Access to Treatment for Chagas Disease in the United States
por: Forsyth, Colin J., et al.
Publicado: (2018)

1210. Recommendations for Screening and Diagnosis of Chagas Disease in the United States
por: Forsyth, Colin, et al.
Publicado: (2021)

Chagas Disease and Healthcare Rights in the Bolivian Immigrant Community of São Paulo, Brazil
por: Aith, Fernando Mussa Abujamra, et al.
Publicado: (2020)

Barriers to Treatment Access for Chagas Disease in Mexico
por: Manne, Jennifer M., et al.
Publicado: (2013)

Progression of Baseline Electrocardiogram Abnormalities in Chagas Patients Undergoing Antitrypanosomal Treatment
por: Soverow, Jonathan, et al.
Publicado: (2019)

Four propositions on integrated sustainability: toward a theoretical framework to understand the environment, peace, and sustainability nexus
por: Fisher, Joshua, et al.
Publicado: (2021)

Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?
por: Picado, Albert, et al.
Publicado: (2017)

New Diagnostic Algorithm for Chagas Disease: Impact on Access to Diagnosis and Out-of-Pocket Expenditures in Colombia
por: OLIVERA, Mario J., et al.
Publicado: (2019)

Prevalence of Chagas Disease Among Family Members of Previously Diagnosed Patients in Los Angeles, California
por: Hernandez, Salvador, et al.
Publicado: (2019)

Prevalence of Chagas Disease in the Latin American–born Population of Los Angeles
por: Meymandi, Sheba K., et al.
Publicado: (2017)

Sleeping habits affect access to host by Chagas disease vector Triatoma dimidiata
por: Waleckx, Etienne, et al.
Publicado: (2016)

Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States
por: Forsyth, Colin J., et al.
Publicado: (2016)

Building a scalable diabetic limb preservation program: four steps to success
por: Khan, Tanzim, et al.
Publicado: (2018)

Evaluation of the Chagas Western Blot IgG Assay for the Diagnosis of Chagas Disease
por: Brossas, Jean-Yves, et al.
Publicado: (2021)

Treatment of Chagas Cardiomyopathy
por: Botoni, Fernando A., et al.
Publicado: (2013)

Intraosseous access can be taught to medical students using the four-step approach
por: Afzali, Monika, et al.
Publicado: (2017)

Access to benznidazole for Chagas disease in the United States—Cautious optimism?
por: Alpern, Jonathan D., et al.
Publicado: (2017)

A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform
por: Pinazo, Maria-Jesus, et al.
Publicado: (2017)

COVID-19: Implications for People with Chagas Disease
por: Zaidel, Ezequiel José, et al.
Publicado: (2020)

Mining SNPs in extracellular vesicular transcriptome of Trypanosoma cruzi: a step closer to early diagnosis of neglected Chagas disease
por: Gaur, Pallavi, et al.
Publicado: (2016)

Use of a Novel Chagas Urine Nanoparticle Test (Chunap) for Diagnosis of Congenital Chagas Disease
por: Castro-Sesquen, Yagahira E., et al.
Publicado: (2014)

Evaluation of the Chagas VirClia(®) and Chagas TESA VirClia(®) for the Diagnosis of Trypanosoma cruzi Infection
por: García-Bermejo, Isabel, et al.
Publicado: (2022)

WHF IASC Roadmap on Chagas Disease
por: Echeverría, Luis Eduardo, et al.
Publicado: (2020)

Stability Assessment of Four Chimeric Proteins for Human Chagas Disease Immunodiagnosis
por: Celedon, Paola Alejandra Fiorani, et al.
Publicado: (2021)

Sustainable Development and SDG-7 in Sub-Saharan Africa: Balancing Energy Access, Economic Growth, and Carbon Emissions
por: Li, Dmitriy, et al.
Publicado: (2022)

Indicators of sustainable capacity building for health research: analysis of four African case studies
por: Bates, Imelda, et al.
Publicado: (2011)

Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2016)

Performance Assessment of Four Chimeric Trypanosoma cruzi Antigens Based on Antigen-Antibody Detection for Diagnosis of Chronic Chagas Disease
por: Santos, Fred Luciano Neves, et al.
Publicado: (2016)

Updating recommendations of the Brazilian Group of Flow Cytometry (GBCFLUX) for diagnosis of acute leukemias using four-color flow cytometry panels
por: Beltrame, Míriam P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nmgt4mdfbv0eu16c4753njb7ds